enGene Therapeutics Inc. (ENGN)
enGene Therapeutics Inc. (ENGN) Insider Trading
Directors, officers and holders of more than 10% of ENGN report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 54 transactions on file: 12 with code P, 0 with code S and 38 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Grossman William | Interim Chief Medical Officer | P Purchase | 5,102 | $1.97 | $10,051 |
| Jun 16, 2026 | Joustra Wouter | Director | A Award | 31,000 | Not measured | Not measured |
| Jun 16, 2026 | Heffernan Michael Thomas | Director | A Award | 31,000 | Not measured | Not measured |
| Jun 16, 2026 | HASTINGS PAUL J | Director | A Award | 31,000 | Not measured | Not measured |
| Jun 16, 2026 | Grossman William | Interim Chief Medical Officer | A Award | 200,000 | Not measured | Not measured |
| Jun 16, 2026 | Grossman William | Interim Chief Medical Officer | A Award | 31,000 | Not measured | Not measured |
| Jun 16, 2026 | Astley-Sparke Philip | Director | A Award | 31,000 | Not measured | Not measured |
| Jun 16, 2026 | Glickman Richard M | Director | A Award | 31,000 | Not measured | Not measured |
| Jun 16, 2026 | Zoth Lota S. | Director | A Award | 31,000 | Not measured | Not measured |
| Jun 16, 2026 | BRUNK GERALD A | Director | A Award | 31,000 | Not measured | Not measured |
| Jan 30, 2026 | CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | A Award | 195,000 | Not measured | Not measured |
| Jan 30, 2026 | Buck Jill | Chief Development Officer | A Award | 195,000 | Not measured | Not measured |
| Jan 30, 2026 | Connolly Joan | Chief Technology Officer | A Award | 195,000 | Not measured | Not measured |
| Jan 30, 2026 | Cooper Ronald Harold Wilfred | CEO & President | A Award | 801,000 | Not measured | Not measured |
| Jan 30, 2026 | Daws D. Ryan | Chief Financial Officer | A Award | 220,000 | Not measured | Not measured |
| Jan 30, 2026 | Nichols Alexander Julian | Chief Strategy & Ops. Ofc | A Award | 195,000 | Not measured | Not measured |
| Jan 30, 2026 | Boyd Matthew Ross | Chief Regulatory Officer | A Award | 195,000 | Not measured | Not measured |
| Jan 30, 2026 | Giguere Lee | Chief Legal Ofc. and Corp Secy | A Award | 195,000 | Not measured | Not measured |
| Sep 30, 2025 | Sweiti Hussein | Chief Medical Officer | A Award | 600,000 | Not measured | Not measured |
| Jul 8, 2025 | Buck Jill | Chief Development Officer | A Award | 100,000 | Not measured | Not measured |
| Jul 8, 2025 | Astley-Sparke Philip | Director | A Award | 45,000 | Not measured | Not measured |
| Jul 8, 2025 | Heffernan Michael Thomas | Director | A Award | 45,000 | Not measured | Not measured |
| Jul 8, 2025 | Grossman William | Interim Chief Medical Officer | A Award | 45,000 | Not measured | Not measured |
| Jul 8, 2025 | Boyd Matthew Ross | Chief Regulatory Officer | A Award | 100,000 | Not measured | Not measured |
| Jun 16, 2025 | Pott Amy | Chief Global Comm. Ofc. | A Award | 400,000 | Not measured | Not measured |
| Jun 16, 2025 | Joustra Wouter | Director | A Award | 22,500 | Not measured | Not measured |
| Jun 16, 2025 | HASTINGS PAUL J | Director | A Award | 22,500 | Not measured | Not measured |
| Jun 16, 2025 | Glickman Richard M | Director | A Award | 22,500 | Not measured | Not measured |
| Jun 16, 2025 | BRUNK GERALD A | Director | A Award | 22,500 | Not measured | Not measured |
| Jun 16, 2025 | Bos Jasper | Director | A Award | 22,500 | Not measured | Not measured |
| Jun 16, 2025 | Zoth Lota S. | Director | A Award | 22,500 | Not measured | Not measured |
| Jan 29, 2025 | CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | A Award | 250,000 | Not measured | Not measured |
| Jan 29, 2025 | Cooper Ronald Harold Wilfred | CEO & President | A Award | 850,000 | Not measured | Not measured |
| Jan 29, 2025 | Pruthi Raj Som | Chief Medical Officer | A Award | 280,000 | Not measured | Not measured |
| Jan 29, 2025 | Nichols Alexander Julian | Chief Strategy & Ops. Ofc | A Award | 250,000 | Not measured | Not measured |
| Jan 29, 2025 | Giguere Lee | Chief Legal Ofc. and Corp Secy | A Award | 250,000 | Not measured | Not measured |
| Jan 29, 2025 | Daws D. Ryan | Chief Financial Officer | A Award | 280,000 | Not measured | Not measured |
| Oct 30, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | P Purchase | 561,797 | $8.90 | $4,999,993 |
| Oct 21, 2024 | CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | A Award | 100,000 | Not measured | Not measured |
| Oct 21, 2024 | Connolly Joan | Chief Technology Officer | A Award | 210,000 | Not measured | Not measured |
| Oct 8, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | P Purchase | 800 | $6.60 | $5,278 |
| Oct 7, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | P Purchase | 11,844 | $6.55 | $77,531 |
| Oct 4, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | P Purchase | 5,997 | $6.54 | $39,242 |
| Oct 3, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | P Purchase | 5,769 | $6.48 | $37,397 |
| Oct 2, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | P Purchase | 10,153 | $6.37 | $64,697 |
| Oct 1, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | P Purchase | 35,279 | $6.44 | $227,158 |
| Sep 30, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | P Purchase | 341,332 | $6.34 | $2,163,362 |
| Sep 27, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | P Purchase | 3,243 | $6.38 | $20,688 |
| Sep 27, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | P Purchase | 38,396 | $5.94 | $228,011 |
| Sep 27, 2024 | Cooper Ronald Harold Wilfred | CEO & President | P Purchase | 10,000 | $5.70 | $57,000 |
The full Form 4 history is on the ENGN company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.